瑞德西韦上市，猜猜多少钱一疗程?
- 主题发起人 rentcfc
- 开始时间
已经被武汉病毒所抢注专利。
问题是不是这药没效了吗，谁会高价买啊。
Hard Worker
本站元老
- 注册
- 2012-08-31
- 消息
- 4,074
- 荣誉分数
- 1,312
- 声望点数
- 373
作为安慰药也太黑了！
这药效果和连花清瘟差不多，国内人应该会吃连花清瘟吧。不过新冠国内免费治的，轻症重症都是住院治疗，所以钱的事情也不用担心。现在国内没听说有死亡得了。
- 注册
- 2005-11-23
- 消息
- 30,291
- 荣誉分数
- 7,455
- 声望点数
- 373
FDA
来源: fuz 于 2020-06-30 09:54:29
叫停“枪魁”，在为“xx的希望”鸣锣开道
Coronavirus (COVID-19) Update: FDA Warns of Newly Discovered Potential Drug Interaction That May Reduce Effectiveness of a COVID-19 Treatment Authorized for Emergency Use
Based on a recently completed non-clinical laboratory study, the FDA is revising the fact sheet for health care providers that accompanies the drug to state that co-administration of remdesivir and chloroquine phosphate or hydroxychloroquine sulfate is not recommended as it may result in reduced antiviral activity of remdesivir. The agency is not aware of instances of this reduced activity occurring in the clinical setting but is continuing to evaluate all data related to remdesivir.
那么，“希望”在哪里
https://www.washingtonpost.com/business/2020/06/29/gilead-sciences-remdesivir-cost-coronavirus/
Gilead sets price of coronavirus drug remdesivir at $3,120 as Trump administration secures supply for 500,000 patients
Gilead Sciences, the maker of the first covid-19 treatment found to have worked in clinical trials, remdesivir, said Monday it will charge U.S. hospitals $3,120 for the typical patient with private insurance.
Soon after the announcement, the Trump administration said it had secured nearly all of the company’s supply of the drug for use in U.S. hospitals through September, with a contract for 500,000 treatment courses, which it will make available to hospitals at Gilead’s price.
更TM缺德的是：卖给其它国家会便宜1/4。发展中国家更低。
Other developed countries will pay 25 percent less than the United States, a discount Gilead said reflects a need to make the drug as widely available as possible throughout the world.
The company has licensed generic manufacturers to produce the drug for developing countries, which will receive the treatment “at a substantially lower cost,” the company said.
来源: fuz 于 2020-06-30 09:54:29
叫停“枪魁”，在为“xx的希望”鸣锣开道
Coronavirus (COVID-19) Update: FDA Warns of Newly Discovered Potential Drug Interaction That May Reduce Effectiveness of a COVID-19 Treatment Authorized for Emergency Use
Based on a recently completed non-clinical laboratory study, the FDA is revising the fact sheet for health care providers that accompanies the drug to state that co-administration of remdesivir and chloroquine phosphate or hydroxychloroquine sulfate is not recommended as it may result in reduced antiviral activity of remdesivir. The agency is not aware of instances of this reduced activity occurring in the clinical setting but is continuing to evaluate all data related to remdesivir.
那么，“希望”在哪里
https://www.washingtonpost.com/business/2020/06/29/gilead-sciences-remdesivir-cost-coronavirus/
Gilead sets price of coronavirus drug remdesivir at $3,120 as Trump administration secures supply for 500,000 patients
Gilead Sciences, the maker of the first covid-19 treatment found to have worked in clinical trials, remdesivir, said Monday it will charge U.S. hospitals $3,120 for the typical patient with private insurance.
Soon after the announcement, the Trump administration said it had secured nearly all of the company’s supply of the drug for use in U.S. hospitals through September, with a contract for 500,000 treatment courses, which it will make available to hospitals at Gilead’s price.
更TM缺德的是：卖给其它国家会便宜1/4。发展中国家更低。
Other developed countries will pay 25 percent less than the United States, a discount Gilead said reflects a need to make the drug as widely available as possible throughout the world.
The company has licensed generic manufacturers to produce the drug for developing countries, which will receive the treatment “at a substantially lower cost,” the company said.
